Search clinical trials for: Relapsed, refractory hematologic malignancies

Total 23783 results

Sanofi

Completed

VALID : VAlproate Versus LIthium in Bipolar Disorders

Bipolar Disorder
University Hospital, Bonn

Unknown

Primary Anatomical Versus Primary Electrophysiological Approach in Circumferential Pulmonary Vein Ablation (CPVA-PAF)

Paroxysmal Atrial Fibrillation
Tri-Service General Hospital

Unknown

A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy

Breast Cancer | Neutropenia | Chemotherapy

Taiwan
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; International...

Terminated

Assessing Repetitive Transcranial Magnetic Stimulation as a Treatment for Refractory Depression (rTMS)

Depression

France
European Georges Pompidou Hospital

Completed

Evolution of Visual Impairment During Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum

France
FibroGen

Completed

A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin

Renal Anemia

United States
Abbott

Withdrawn

A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

Asthma
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
German AML Cooperative Group

Unknown

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

Relapsed Acute Promyelocytic Leukemia | Refractory Acute Promyelocytic Leukemia

Germany
University of Wuerzburg

Unknown

Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years

Multiple Myeloma

Germany, Austria
Johann Wolfgang Goethe University Hospital

Unknown

Study Comparing Imatinib With Chemotherapy as Induction in Elderly Patients With Philadelphia Positive Acute Lymphoblastic Leukemia (ALL)

Philadelphia Positive Acute Lymphoblastic Leukemia | Lymphoid Blastic Phase of Chronic Myeloid Leukemia

Germany
Recoly N.V.

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

Haemophilia A

Russian Federation
Cortice Biosciences, Inc.

Completed

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Neoplasms | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Eli Lilly and Company

Completed

Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis

Osteoporosis, Postmenopausal

Korea, Republic of
Swedish Medical Center
Novartis

Completed

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Colorectal Cancer

United States
Sheba Medical Center

Unknown

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Leukemia, Myeloid, Philadelphia-Positive

Israel
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma

Hematologic Neoplasms

United States, Canada
Rambam Health Care Campus

Unknown

Concurrent Xeloda and Radiotherapy for Bone Metastases

Bone Metastases | Solid Tumors

Israel
Octagen Corporation
Biomeasure Inc, Ipsen Group

Completed

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Hemophilia A

United States
Herlev Hospital
Eli Lilly and Company; Sanofi

Completed

Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer

Prostate Cancer

Denmark
National Cancer Institute (NCI)

Completed

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Multiple Myeloma | Graft vs Host Disease

United States
Weintraub, Michael I., MD, FACP, FAAN
Dr. Steven P. Cole, PhD. Statistician

Completed

Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome

Refractory Carpal Tunnel Syndrome | Neurpathic Pain | Neuromodulaton

United States
Icagen
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Terminated

A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy

Sickle Cell Disease | Sickle Cell Anemia

United States
Daiichi Sankyo, Inc.

Completed

Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component)

Lymphoma | Malignancies

United States
Cytogen Corporation

Unknown

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer (CYT-500)

Metastatic Prostate Cancer

United States
Prothya Biosolutions
Landsteiner Foundation for Blood Transfusion

Completed

Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

Neutropenia | MBL-Deficient

Netherlands
Prothya Biosolutions

Completed

Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)

Hemophilia B

Netherlands
HaEmek Medical Center, Israel

Completed

Thrombophilia and Migraine, Are They Related?

Thrombosis | Migraine | Thrombophilia

Israel
Duke University

Completed

Hydroxyurea in Young Children With Sickle Cell Anemia

Sickle Cell Anemia

United States
Abbott

Completed

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Lymphoma, Non-Hodgkin | Hodgkin's Lymphoma

United States
Abbott

Completed

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Prostatic Neoplasms

Canada, United States, Spain, Belgium, Australia, Italy, United Kingdom, Germany, France, Sweden, South Africa, Netherlands, Ireland, New Zealand, Greece, Poland, Austria
Zhejiang University

Unknown

The Effect of Early Iron Deficiency on Developmental Brain and Behavior in Infants (IDBB)

Iron Deficiency

China
University of Bologna
Novartis

Completed

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day) (CML022)

Chronic Myeloid Leukemia

Italy
University of Bologna

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase (CML003)

Chronic Myeloid Leukemia

Italy
University of Thessaly

Unknown

Multicentre Prospective Clinical Trial for RFA Tumour Aspirator Treatment of Primary and Secondary Malignancies of the Liver

Liver Cancer

Greece
University of Bologna
Novartis; Schering-Plough

Terminated

Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)

Chronic Myeloid Leukemia
University of Bologna
Novartis

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia

Chronic Myeloid Leukemia
University of Bologna

Completed

Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

Italy
Sundsvall Hospital

Completed

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Multiple Myeloma | Anemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Sweden
Instituto Nacional de Salud Publica, Mexico

Completed

Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in Mexico

Anemia | Iron Deficiency | Stunting

Mexico
Assaf-Harofeh Medical Center

Unknown

Gastrointestinal Evaluation in Young Men With Iron Deficiency Anemia

Anemia, Iron-Deficiency

Israel
Hospital Clinic of Barcelona
Agencia Española de Cooperación Internacional; World Health Organization

Terminated

RCT Iron Supplementation and Malaria Chemoprophylaxis for Prevention of Severe Anemia and Malaria in Tanzanian Infants

Anemia | Malaria

Tanzania
Christian Medical College, Vellore, India

Unknown

Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease

Graft vs Host Disease

India
Spital Zollikerberg
Viollier Inc.

Completed

Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency (SFIDS)

Functional Iron Deficiency

Switzerland
Eunice Kennedy Shriver National Institute of Child...
Children's Hospital Medical Center, Cincinnati

Unknown

Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome

Twin to Twin Transfusion Syndrome

United States
Ophthalmic Consultants of Boston
Bausch & Lomb Incorporated

Unknown

Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser

Diabetic Macular Edema

United States
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Thrombophilia and Thyroid Autoimmunity in Implantation Failure and Recurrent Miscarriage

Thrombophilia, Thyroid Autoimmunity

Spain
Point Therapeutics

Terminated

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small Cell Lung

United States
Urological Sciences Research Foundation
Allergan

Unknown

This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. (BTX0621)

Overactive Bladder

United States
Soroka University Medical Center

Unknown

Prevention of Iron Deficiency in 2nd Year of Life

Anemia | Iron Deficiency

Israel

3

Subscribe